0775:HKG
CK Life Sciences Intl (Holdings) Inc
0,51 HK$
0,00%
(0,00) 1 d.
16. okt., 16:08:14 GMT+8 · HKD
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: 0775…
Atvērt
0,51 HK$
Augsta
0,52 HK$
Zema
0,51 HK$
Tirgus kapitalizācija
4,90 mljrd.
Vid. apjoms
1,66 milj.
Apjoms
956,00 tūkst.
Augstākā 52 ned.
1,02 HK$
Zemākā 52 ned.
0,51 HK$
Peļņa uz vienu akciju
-0,01 HK$
Apgrozībā esošās akcijas
9,61 mljrd.
Darbinieku skaits
2 tūkst.
Atvērt
0,51 HK$
Augsta
0,52 HK$
Zema
0,51 HK$
Tirgus kapitalizācija
4,90 mljrd.
Vid. apjoms
1,66 milj.
Apjoms
956,00 tūkst.
Augstākā 52 ned.
1,02 HK$
Zemākā 52 ned.
0,51 HK$
Peļņa uz vienu akciju
-0,01 HK$
Apgrozībā esošās akcijas
9,61 mljrd.
Darbinieku skaits
2 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Simply Wall Street
·
pirms 22 minūtēm
Does Stablecoin Backed Cards Change The Bull Case For Marqeta (MQ)?
Yahoo Finance
·
pirms 3 stundām
Michael Burry Warns Stock Market Could Be Months Away From A 2000-Style Reckoning — ‘The Preconditions Seem Set For Fireworks’
The Motley Fool
·
pirms 45 minūtēm
The 10-Year Treasury Is Above 5% for the First Time in Almost 20 Years. History Says This Is How the S&P 500 Index Will Perform Over the Next 12 Months.
AOL.com
·
pirms 3 stundām
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
Profils
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
Par “CK Life Sciences Intl (Holdings) Inc”
ĢenerāldirektorsYing Choi Yu
Darbinieki1,92 tūkst.
Dibināšanas datums2000
Galvenais birojs-
Sektors-
Tīmekļa vietneck-lifesciences.com